Precigen (PGEN) Preferred Dividend Payments (2012 - 2025)
Precigen's (PGEN) quarterly Preferred Dividend Payments came in at $179.0 million in Q3 2025, up 4326.31% on a QoQ basis from $4.0 million in Q3 2013.
Precigen (PGEN) Preferred Dividend Payments (2012 - 2025) Analysis & Trends
Precigen (PGEN) has 3 years of Preferred Dividend Payments data on file, last reported at $179.0 million in Q3 2025.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $179.0 million in Q3 2025; TTM through Dec 2025 was $179.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $179.0 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q3 2025 stood at $179.0 million, up from $4.0 million in the prior quarter.
- Over the last five years, Preferred Dividend Payments for PGEN reached as high as $179.0 million in Q3 2025 and fell as low as $179.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 179.00 Mn |
| Sep 30, 2013 | 4.04 Mn |
| Jun 30, 2013 | 7.94 Mn |
| Mar 31, 2013 | 6.41 Mn |
| Dec 31, 2012 | 5.70 Mn |
| Sep 30, 2012 | 5.47 Mn |
| Jun 30, 2012 | 5.36 Mn |